Page 21234..1020..»

Category Archives: ALS Treatment

New Treatment Strategy Offers Hope for Halting ALS Progression – Northeastern University

Posted: Published on February 4th, 2024

A major breakthrough in the treatment of amyotrophic lateral sclerosis, known as ALS, can potentially help stop the disease in its tracks in as much as half of the cases in the U.S., a Northeastern University scientist says. Jeffrey Agar, associate professor of chemistry and pharmaceutical sciences at Northeastern, has spent the last 12 years studying the mechanism of ALS and researching ways to prevent its progression. Continue reading

Posted in ALS Treatment | Comments Off on New Treatment Strategy Offers Hope for Halting ALS Progression – Northeastern University

Aaron Lazar Says He Won’t ‘Fight’ ALS After His Diagnosis: ‘There’s Nothing to Beat’ – PEOPLE

Posted: Published on February 4th, 2024

Aaron Lazar is opening up about his diagnosis with amyotrophic lateral sclerosis (ALS), and revealing why he's not focused on trying to fight the disease for which there is no cure, but instead move through life with courage and hope. The stage veteran known for two decades of roles on Broadway and on tour in musicals like The Light in the Piazza, Dear Evan Hansen, Les Misrables, A Little Night Music and The Last Ship went public in January with the news that he had the progressive neurogenerative disorder, after being diagnosed two years ago. During a candid interview on The Broadway Show with Tamsen Fadal, the 47-year-old actor and singer explained he's since been on a healing journey" focused on taking care of his mind, body and spirit. Continue reading

Posted in ALS Treatment | Comments Off on Aaron Lazar Says He Won’t ‘Fight’ ALS After His Diagnosis: ‘There’s Nothing to Beat’ – PEOPLE

Insights from a phase II clinical trial with CL2020 Muse cell-based therapeutic for Amyotrophic lateral sclerosis – EurekAlert

Posted: Published on February 4th, 2024

image: The image above describes the changes in the mean scores for the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R) for ALS patients treated with CL2020. Continue reading

Posted in ALS Treatment | Comments Off on Insights from a phase II clinical trial with CL2020 Muse cell-based therapeutic for Amyotrophic lateral sclerosis – EurekAlert

Phase 3 clinical trial of pridopidine in ALS patients likely this year – ALS News Today

Posted: Published on February 4th, 2024

On the heels of promising HEALEY-ALS Phase 2 trial data, Prilenia Therapeutics plans to launch a pivotal Phase 3 study of pridopidine, its candidate amyotrophic lateral sclerosis (ALS) treatment, in the second half of this year. Relative to a placebo, pridopidine was associated with slower disease progression, a better life quality, and a potential to prolong survival in patients in early disease stages. These recently diagnosed ALS patients with rapidly progressing symptoms saw particular benefit in terms of respiratory health and speech, although better speech was evident across all treated patients Continue reading

Posted in ALS Treatment | Comments Off on Phase 3 clinical trial of pridopidine in ALS patients likely this year – ALS News Today

ALS Agent CNM-Au8 Reduces NfL, Positive CLEAR-MIND Results, Decreased Learning Abilities in Narcolepsy – Neurology Live

Posted: Published on January 8th, 2024

WATCH TIME: 3 minutes Clene Nanomedicine recently announced positive data from the open-label extension phase of the HEALEY-ALS trial, with results showing that treatment with investigational CNM-Au8 resulted in reduced plasma neurofilament light levels and improved survival among patients with ALS. Continue reading

Posted in ALS Treatment | Comments Off on ALS Agent CNM-Au8 Reduces NfL, Positive CLEAR-MIND Results, Decreased Learning Abilities in Narcolepsy – Neurology Live

Dewpoint Therapeutics Advances in ALS Treatment with Novel Patent Applications – BNN Breaking

Posted: Published on January 8th, 2024

Dewpoint Therapeutics Advances in ALS Treatment with Novel Patent Applications Dewpoint Therapeutics Inc., a leading biotechnology firm specializing in the groundbreaking science of condensates, has made a significant stride in the fight against neurodegenerative diseases. Continue reading

Posted in ALS Treatment | Comments Off on Dewpoint Therapeutics Advances in ALS Treatment with Novel Patent Applications – BNN Breaking

Restarting New Year’s resolutions with 3 goals to support the ALS… – ALS News Today

Posted: Published on December 31st, 2023

Im not a big believer in making New Years resolutions. Theres something that feels bad about setting a goal thats lofty learning a new language is one of my perennial favorites, for example and then not accomplishing it. Plus, I keep a daily to-do list that includes some small self-improvement items, and I work regularly, and with mixed results, to attain those Continue reading

Posted in ALS Treatment | Comments Off on Restarting New Year’s resolutions with 3 goals to support the ALS… – ALS News Today

Opinion | A Rejected A.L.S. Drug Made Me Rethink the Role of Hope in Medicine – The New York Times

Posted: Published on December 31st, 2023

Of all the ways the body can go wrong, A.L.S. is one of the most frightening Continue reading

Posted in ALS Treatment | Comments Off on Opinion | A Rejected A.L.S. Drug Made Me Rethink the Role of Hope in Medicine – The New York Times

Mitsubishi Tanabe Pharma America Announces Presentations in ALS at 34th International Symposium on ALS/MND – PR Newswire

Posted: Published on December 6th, 2023

JERSEY CITY, N.J., Dec. 5, 2023 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that four abstracts in amyotrophic lateral sclerosis (ALS) will be presented at the Motor Neurone Disease Association (MNDA) 34th International Symposium on ALS/MND, being held in Basel, Switzerland, from December 6-8 Continue reading

Posted in ALS Treatment | Comments Off on Mitsubishi Tanabe Pharma America Announces Presentations in ALS at 34th International Symposium on ALS/MND – PR Newswire

FDA meets with BrainStorm Cell Therapeutics to discuss NurOwn for ALS – Pharmaceutical Technology

Posted: Published on December 6th, 2023

ALS is a rare disease with difficult treatment due to its complex pathophysiology. Credit: Zerbor via Shutterstock. Continue reading

Posted in ALS Treatment | Comments Off on FDA meets with BrainStorm Cell Therapeutics to discuss NurOwn for ALS – Pharmaceutical Technology

Page 21234..1020..»